Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Risk communication of study drug side effects: An evaluation of informed consent forms from ClinicalTrials.gov.
Journal: Patient education and counseling
Published: January 22, 2025
Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 Pandemic.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: July 18, 2022
Risk Minimization of Antibody-Drug Conjugates in Oncology: A Review.
Journal: Drug safety
Published: April 02, 2021
Best-practices for the design and development of prescription medication information: A systematic review.
Journal: Patient education and counseling
Published: September 11, 2017
An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining.
Journal: Therapeutic innovation & regulatory science
Published: January 01, 2017
The future of safety science is happening now: The modernization of the benefit-risk paradigm.
Journal: Pharmacoepidemiology and drug safety
Published: December 19, 2016
Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 04, 2013
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Journal: Annals of neurology
Published: February 07, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026